<DOC>
	<DOC>NCT01566578</DOC>
	<brief_summary>Investigation of EGF-Receptor Downregulation by topical EGF (dermal cream) exposition.</brief_summary>
	<brief_title>A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Informed consent Mild to moderate psoriasis (all types) with active plaques on both body sides accessible for biopsy and self product application EGFR immunohistochemistry score &gt; 5 Male Age 1860 years Systemic psoriasis treatment 3 months prior and during the study Local psoriasis treatment on the investigational sites in the last 30 days or during the study Known hypersensitivity or allergy to the EGF containing product (Newskin) and/or to Vaseline/10% salicylic acid and/or to local anaesthetics of the amid type Known or suspected noncompliance to study protocol Coagulopathy or treatment with anticoagulants History of malignant disease Other clinically relevant concomitant disease state Participation in another investigational drug study in the last 30 days</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>